BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 27495245)

  • 1. Warfarin with sulfonylureas and hypoglycemic events: consider dose, length of treatment, and all sulfonylureas.
    Bosco-Lévy P; Salvo F
    BMJ; 2016 Aug; 354():i4328. PubMed ID: 27495245
    [No Abstract]   [Full Text] [Related]  

  • 2. Authors' reply to Bosco-Lévy and Salvo.
    Romley JA; Gong C; Jena AB; Goldman DP; Williams B; Peters A
    BMJ; 2016 Aug; 354():i4330. PubMed ID: 27496026
    [No Abstract]   [Full Text] [Related]  

  • 3. Serious Hypoglycemia and Use of Warfarin in Combination With Sulfonylureas or Metformin.
    Nam YH; Brensinger CM; Bilker WB; Leonard CE; Han X; Hennessy S
    Clin Pharmacol Ther; 2019 Jan; 105(1):210-218. PubMed ID: 29885251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HYPOGLYCEMIA INDUCED BY ANTIDIABETIC SULFONYLUREAS.
    Confederat L; Constantin S; Lupaşcu F; Pânzariu A; Hăncianu M; Profire L
    Rev Med Chir Soc Med Nat Iasi; 2015; 119(2):579-84. PubMed ID: 26204670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoglycemia in hospitalized patients treated with sulfonylureas.
    Deusenberry CM; Coley KC; Korytkowski MT; Donihi AC
    Pharmacotherapy; 2012 Jul; 32(7):613-7. PubMed ID: 22570146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoglycemia after antimicrobial drug prescription for older patients using sulfonylureas.
    Parekh TM; Raji M; Lin YL; Tan A; Kuo YF; Goodwin JS
    JAMA Intern Med; 2014 Oct; 174(10):1605-12. PubMed ID: 25179404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sulfonylurea-induced hypoglycemia. An iatrogenic and potentially fatal condition].
    Carlsen SM
    Tidsskr Nor Laegeforen; 1997 Sep; 117(21):3079-82. PubMed ID: 9381441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using pharmacoepidemiological findings to guide clinical practice: sulfonylureas and hypoglycemia in older adults.
    Gurwitz JH
    J Am Geriatr Soc; 1996 Jul; 44(7):871-2. PubMed ID: 8675941
    [No Abstract]   [Full Text] [Related]  

  • 9. Severe hypoglycemia in users of sulfonylurea antidiabetic agents and antihyperlipidemics.
    Leonard CE; Bilker WB; Brensinger CM; Han X; Flory JH; Flockhart DA; Gagne JJ; Cardillo S; Hennessy S
    Clin Pharmacol Ther; 2016 May; 99(5):538-47. PubMed ID: 26566262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-acting sulfonylureas -- long-acting hypoglycaemia.
    Veitch PC; Clifton-Bligh RJ
    Med J Aust; 2004 Jan; 180(2):84-5. PubMed ID: 14723592
    [No Abstract]   [Full Text] [Related]  

  • 11. Diagnosis and treatment of sulfonylurea-induced hyperinsulinemic hypoglycemia.
    Graudins A; Linden CH; Ferm RP
    Am J Emerg Med; 1997 Jan; 15(1):95-6. PubMed ID: 9002583
    [No Abstract]   [Full Text] [Related]  

  • 12. Severe sulfonylurea-induced hypoglycemia: a problem of uncritical prescription and deficiencies of diabetes care in geriatric patients.
    Holstein A; Hammer C; Hahn M; Kulamadayil NS; Kovacs P
    Expert Opin Drug Saf; 2010 Sep; 9(5):675-81. PubMed ID: 20553106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concomitant Use of Sulfonylureas and Warfarin and the Risk of Severe Hypoglycemia: Population-Based Cohort Study.
    Dimakos J; Cui Y; Platt RW; Renoux C; Filion KB; Douros A
    Diabetes Care; 2022 Oct; 45(10):e131-e133. PubMed ID: 35984011
    [No Abstract]   [Full Text] [Related]  

  • 14. Improving management of type 2 diabetes mellitus: 3. Sulfonylureas.
    Samraj GP; Quillen DM; Kuritzky L
    Hosp Pract (1995); 1999 Nov; 34(12):129-34, 137, 140. PubMed ID: 10616550
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hypoglycemic risk of insulinotropic drugs].
    Böhm R; Cascorbi I; Herdegen T
    Med Monatsschr Pharm; 2009 Dec; 32(12):453-8. PubMed ID: 20088347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Practical considerations and guidelines for dosing sulfonylureas as monotherapy or combination therapy.
    Bell DS
    Clin Ther; 2004 Nov; 26(11):1714-27. PubMed ID: 15639686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Measures to meet the side effects of sulfonylurea (SU) in the treatment of type 2 diabetes].
    Furukawa H; Ishida H
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():357-61. PubMed ID: 12387018
    [No Abstract]   [Full Text] [Related]  

  • 18. Dose-response relationship between sulfonylureas and major adverse cardiovascular events in elderly patients with type 2 diabetes.
    Abdelmoneim AS; Eurich DT; Senthilselvan A; Qiu W; Simpson SH
    Pharmacoepidemiol Drug Saf; 2016 Oct; 25(10):1186-1195. PubMed ID: 27102581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prolonged hypoglycemia after oral anti-diabetic drugs].
    Svoboda Z; Beranová M
    Vnitr Lek; 1979 Nov; 25(11):1103-5. PubMed ID: 516491
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of hypoglycemic drugs during lactation.
    Glatstein MM; Djokanovic N; Garcia-Bournissen F; Finkelstein Y; Koren G
    Can Fam Physician; 2009 Apr; 55(4):371-3. PubMed ID: 19366943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.